ResMed (RMD) has been under a strong bear grip, hence the stock is down -2.86% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 2.27% in the past 1 week. The stock has risen by 2.43% in the past week indicating that the buyers are active at lower levels, but the stock is down -3.39% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 0.45% and the 50-Day Moving Average is 3.31%.The 200 Day SMA reached 8.12%
ResMed (NYSE:RMD): After opening at $64.84, the stock dipped to an intraday low of $64.7 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $65.38 and the buying power remained strong till the end. The stock closed at $64.79 for the day, a gain of 0.90% for the day session. The total traded volume was 922,766. The stocks close on the previous trading day was $64.79.
ResMed (RMD) : The most positive equity analysts on ResMed (RMD) expects the shares to touch $74, whereas, the least positive believes that the stock will trade at $50 in the short term. The company is covered by 7 Wall Street Brokerage Firms. The average price target for shares are $61.89 with an expected fluctuation of $8.65 from the mean.
ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.